Y. Itakura

Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors.

P. Jungers, G. Albouze, B. Descamps-Latscha, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The rate of progression of renal failure in ADPKD.

P. Jungers, G. Choukroun, J. Grünfeld, 1995, Contributions to nephrology.

Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients

T. Kuragano, T. Nakanishi, S. Fujimoto, 2020, PloS one.

Hyperhomocysteinemia in patients on dialysis, as determined by the methionine loading test

T. Mitarai, K. Isoda, A. Matsuda, 1997 .

Changes in phenytoin concentrations in blood and cerebrospinal fluid caused by direct hemoperfusion in a patient intoxicated with phenytoin.

Y. Kanayama, T. Mitarai, K. Isoda, 1998, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Eradication of Helicobacter pylori restores elevation of serum gastrin concentrations in patients with end-stage renal disease.

T. Mitarai, K. Isoda, O. Matsumura, 1998, Internal medicine.

ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage

T. Kuragano, T. Nakanishi, H. Kiyomoto, 2016, PloS one.

Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.

P. Jungers, G. Choukroun, J. Grünfeld, 1995, Journal of the American Society of Nephrology : JASN.

A case of congenital dyserythropoietic anemia type II associated with hemochromatosis.

H. Terai, T. Mitarai, H Tamura, 1992, Internal medicine.